Berenberg Bank Issues Positive Forecast for Eli Lilly and Company (NYSE:LLY) Stock Price

Berenberg Bank has raised its price target for Eli Lilly and Company (NYSE:LLY) to $1,050 from $950, maintaining a “hold” rating, suggesting a modest 3.47% upside. This follows Eli Lilly’s strong quarterly performance, which exceeded revenue and EPS expectations, along with increased FY2026 EPS guidance. While Berenberg Bank’s rating is a “hold,” the broader analyst consensus for LLY remains a “Moderate Buy” with an average price target of $1,228.54, indicating significant bullish sentiment from other firms like JPMorgan, Deutsche Bank, and Barclays.